A US citizen doing humanitarian work in the Democratic Republic of Congo has tested positive for Ebola and is being sent to Germany for treatment, Ars Technica reported. The case is the second known American infection in the current DRC outbreak, and the second in which the patient has been directed to Germany rather than to the United States for care.
The decision matters because the United States has built specialized facilities for exactly this kind of problem: monitoring people exposed to Ebola and treating patients with the infection under strict isolation. According to Ars Technica, the Trump administration has instead used travel restrictions and blocked repatriation for US citizens exposed to or infected with the virus.
Outbreak has become one of the largest recorded
The outbreak was first declared on May 15, according to Ars Technica. By July 12, the DRC had reported 1,926 cases and 702 deaths, according to a DRC situation report cited by the outlet.
Those figures already make the outbreak the third largest recorded Ebola outbreak, according to Ars Technica, and officials have not said it has stopped growing. The outbreak is caused by the Bundibugyo strain of Ebolavirus, a less familiar strain than the one most often associated with the largest West African outbreak.
The available reporting does not identify the infected US citizen or the German facility expected to provide care. It also does not give a clinical status for the patient beyond the positive test result.
US policy keeps cases abroad
The reported US posture is a sharp change from the basic premise behind domestic biocontainment capacity. Ebola patients require isolation, trained staff, protective equipment, waste handling, and careful monitoring, but the US has multiple facilities designed for that work, according to Ars Technica.
Instead, the Trump administration has imposed stringent travel restrictions and has blocked the return of citizens with exposure to, or infection with, Ebola, Ars Technica reported. The outlet described the policy as controversial and isolationist.
For the affected Americans, the practical result is straightforward: care is being arranged outside their home country even though domestic Ebola treatment and monitoring infrastructure exists. For public health officials, the decision also shows how border policy can override the medical systems built for rare, high-consequence infections.
The DRC outbreak remains active, with case and death totals still rising as of the July 12 report. The second infected American adds a US policy fight to a public health emergency already straining responders in Central Africa.
This story draws on original reporting from Ars Technica.
